Voyageur Pharmaceuticals (TSXV:VM) YoY EBITDA Growth : -150.00% (As of Feb. 2025)

View and export this data going back to 2012. Start your Free Trial

What is Voyageur Pharmaceuticals YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Voyageur Pharmaceuticals's YoY EBITDA Growth for the quarter that ended in Feb. 2025 was -150.00%.

Voyageur Pharmaceuticals's EBITDA per Share for the three months ended in Feb. 2025 was C$-0.01.

Voyageur Pharmaceuticals YoY EBITDA Growth Historical Data

The historical data trend for Voyageur Pharmaceuticals's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voyageur Pharmaceuticals YoY EBITDA Growth Chart

Voyageur Pharmaceuticals Annual Data

Trend

Dec15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Nov24

YoY EBITDA Growth

Get a 7-Day Free Trial

-60.00

-37.50

27.27

31.25

-9.09

Voyageur Pharmaceuticals Quarterly Data
	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
YoY EBITDA Growth	Get a 7-Day Free Trial															33.33	20.00	-200.00	-50.00	-150.00

Voyageur Pharmaceuticals YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Voyageur Pharmaceuticals's YoY EBITDA Growth for the fiscal year that ended in Nov. 2024 is calculated as:

	YoY EBITDA Growth (A: Nov. 2024 )
=	(EBITDA per Share (A: Nov. 2024 )	-	EBITDA per Share (A: Nov. 2023 ))	/	\| EBITDA per Share (A: Nov. 2023 ) \|
=	(-0.012	-	-0.011)	/	\| -0.011 \|
=	-9.09 %

Voyageur Pharmaceuticals's YoY EBITDA Growth for the quarter that ended in Feb. 2025 is calculated as:

	YoY EBITDA Growth (Q: Feb. 2025 )
=	(EBITDA per Share (Q: Feb. 2025 )	-	EBITDA per Share (Q: Feb. 2024 ))	/	\| EBITDA per Share (Q: Feb. 2024 )) \|
=	(-0.005	-	-0.002)	/	\| -0.002 \|
=	-150.00 %

Voyageur Pharmaceuticals YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Voyageur Pharmaceuticals's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Voyageur Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Voyageur Pharmaceuticals Ltd (TSXV:VM) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

VYYRF:USA

Address

4103B Center Street NW, Calgary, AB, CAN, T2E 2Y6

Website

https://www.voyageurpharmaceuticals.ca

Voyageur Pharmaceuticals Ltd is engaged in acquiring, exploring, and developing raw materials for pharmaceutical products. The company's products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD, and V-Gas.

Executives

Bradley Craig Willis	Director, Senior Officer
Trent Abraham	Director
Charles Littlejohn	10% Security Holder

Voyageur Pharmaceuticals Headlines

No Headlines